575
40222226014562124
PŘEHLEDOVÝ852207016974156235334409485586692777867
ČLÁNEK1757207016989163260360438521
Ces8507936014570127174
Urol10497936014578115180208
2020;12827936014562121178237261
24(1):15697936014561118151206230252
26–4118467936014562120184249301
30.850896013356115140
El‑Hashemite101789601336493131207264310373431526555594651
N,1695896013383109
Walker1841896013393147175229286325
V,219289601337392
Zhang2310896013372135191254319
H,2656896013382108
Kwiatkowski2791896013370151180235274328390473519573603
DJ.3421896013384124149
Loss3598898013160120164207
of3832898013169101
Tsc1396189801316297149199
or4187898013169105
Tsc2431989801316297149207
induces455389801313495158218270324368
vascular4948898013161114157209269295347381
endothelial8501048013153115177239274336392418443494520
growth1398104801316095155236276338
factor1763104801313084136175235270
production2062104801316096155219279331371396457519
through2608104801313697131191252315376
mammalian30131048013190142234326379404429480542
target3582104801313588123184240276
of3887104801315890
rapamycin.4005104801313386149202295344395420481503
Cancer45361048013163116177229283318
Res.48811048013157114157180
2003;50881048013155110168222241
63(17):8501198013154108138188235268288
5173–5177.11651198013157107154209267322372419474484
31.8501346013357108125
Chen10071346013365126182244
YB,12751346013368129152
Mirsadraei14591346013390116152197251314350404460486
L,1969134601336085
Jayakumaran20781346013349102153207259320413466502556617
G,2727134601337297
et28481346013364101
al.2973134601336287110
Somatic31081348013160120211261293316365
Mutations35061348013187146180230263286345404444
of3975134801316897
TSC240961348013160113175230
or43511348013168100
MTOR44841348013187139211267
Characterize47761348013171130180212263312349401433456501554
a8501498013150
Morphologically9321498013186144176237296354378436496518566616638660708
Distinct1672149801317294133168190248297333
Subset20291498013159116176216269302
of2355149801316795
Sporadic24751498013159118177209259319341389
Renal28881498013164117175224246
Cell31581498013171122145167
Carcinoma33491498013171121152199221278337427476
With38571498013190114147205
Eosinophilic40861498013160117157178236294355413435457479527
and46371498013158116176
Vacuolated48371498013164111160217276299348380431491
Cytoplasm.8501648013163104141197258281329369458477
Am13511648013164153
J15281648013138
Surg15901648013151108139197
Pathol.18111648013156104136194252275294
2019;21291648013153105153198216
43(1):23691648013154103129177197213
121–131.2607164801315398145194240285331344
32.8501796013356109132
Franz1008179601335486139199246
DN,12801796013373146169
Budde14751796013359119181243298
K,1799179601336085
Kingswood1910179601336086147208250332391452514
JC,24481796013343107131
et2605179601335591
al.2722179601335378101
Effect2847179801315482112164213249
of3123179801315987
everolimus32341798013156105157188245268289378435474
on37351798013159117
skin3876179801314489113170
lesions4070179801312679119141198257296
in4390179801312684
patients45001798013161111143165218276307349
treated4873179801313769120168200251312
for5209179801313188120
subependymal850194801314196155208267320378436484573621643
giant1512194801316081129186217
cell1748194801314999121142
astrocytoma1910194801315089123154210258308345400489537
and24671948013149106165
renal2655194801312979136185206
angiomyolipoma:28811948013149106165186243332377434456477536594683731748
final3648194801312753110158179
4-year3847194801315387135186233264
results4134194801312979119175196229270
from4428194801312457112201
the4652194801313087140
randomized4815194801312978135193251339360404454514
EXIST-18502098013151112134183235261307
and11822098013149107167
EXIST-213732098013151112134182235261307
studies.1704209801314276134193215268308327
J20552098013138
Eur21172098013152107138
Acad22792098013165112162221
Dermatol25242098013172125157247296328384407
Venereol.29552098013156105163216248299358381399
2018;33792098013153105153199216
32(10):36192098013154103128175223250266
1796–1803.3909209801315498148202260306352406456474
33.8502246013356110131
Bissler1007224601336085128170195250286
JJ,1316224601334483104
Kingswood1446224601335986146208250331391452514
JC,19832246013344108132
Radzikowska21412246013359112174221246297355435478529583
E,2750224601335476
et2852224601335592
al.2970224601335378101
Everolimus30952248013154102154185242265286375432472
long‑term3591224801312684142202235268319350440
use4058224801315998151
in4233224801312683
patients43432248013161111143165218276307349
with47192248013179102135193
tuberous4936224801313795154208240296354394
sclerosis850239801314190112165196253293314353
complex:12272398013149105195254277330378398
Four‑year16492398013150107165196225273325373405
update20782398013158118178227259310
of2412239801315887
the2523239801313492145
EXIST-226922398013151112134183235262308
study.3024239801314175133193241254
PLoS33022398013156103159207
One.35332398013174133186203
2017;37602398013154106153197210
12(8):3994239801315498123174201217
e0180939.42352398013154108156202256309359409424
34.8502546013356114137
Bissler1012254601336693136180206262299
JJ,1336254601334787110
Kingswood1470254601336794156218262344404466530
JC,20242546013348113138
Radzikowska21872546013366120183231257309369450494546601
E,2812254601336185
et29212546013362100
al.3045254601336087110
Everolimus31812548013158108160193251275297387445486
for3692254801313694127
angiomyolipoma38452548013157115176199258348396454478501561622712762
associated4632254801315898139199249272321355407468
with51332548013179103137196
tuberous850269801313492151205237294352392
sclerosis1266269801313887110163195251292314353
complex16412698013148104194254277330378
or2041269801315890
sporadic2156269801313897156189239299321370
lymphangioleiomyomatosis2550269801312169159219277326384444466524548601623681771817874964101310461102114211641203
(EXIST-2):3778269801312676137159208260287334361378
a41782698013149
multicentre,42492698013189146169203225274325383415447499516
randomised,4790269801312979137197255345367406460520539
double‑blind,8502848013160119178239263317353415439461520581600
placebo‑controlled1476284801316185135184236297357393446503562595628686710733787848
trial.234928480131356892141165184
Lancet25582848013151102161211263297
2013;28812848013154107156201218
381(9869):31262848013153106155178228282337389416434
817–824.35872848013153102147197253305354372
35.8502996013356110130
Staehler1007299601335488141196257282337373
M,14062996013389113
Sauter15452996013354107167203256292
M,18632996013389113
Helck20022996013372127153202253
A,2281299601336792
et2399299601335592
al.2517299601335378101
Nephron‑sparing26452998013170123183242273329388421462521571602625682742
resection3411299801313587127180229266288345404
of3842299801315987
angiomyolipoma39532998013153111170192250339385443466487547606695744
after4721299801315381119170201
sirolimus494629980131446697153176198287344383
pretreatment850314801316193144177209261309341430483541573
in1447314801312381
patients15523148013161110143165217275307349
with19253148013179102135193
tuberous2142314801313492151205237293351391
sclerosis.2557314801314189112164196252292314353372
Int2953314801312381113
Urol30903148013169100156179
Nephrol.32933148013171124183242273330353371
2012;36883148013154106153198215
44(6):39273148013154110139189216232
1657–1661.41833148013154101152202251297344398443455
36.8503296013356112134
Ürge10143296013371106166221
T,1259329601336076
Pitra1364329601335983119154207
T,1594329601336177
Chudáček17003296013364123183245297346399451
Z,2180329601336184
et2287329601336198
al.2408329601335984107
Nové25453298013170129177229
trendy2798329801314072123181240289
v31113298013156
léčbě3191329801312982131190244
renalního3459329801313990148197219277298358417
angiomyolipomu.39003298013156114173195252342388445469490549609698755774
Ces47043298013163114154
Urol.4889329801316899156179197
2015;51103298013160112159204219
19(2):850344801315499127178204221
106–117.10953448013154101155213259300344351
37.8503596013356109120
Moch9903596013388149199259
H,1269359601337295
Cubilla13843596013363121183209234259311
AL,17153596013368118142
Humphrey18773596013372132223285346381436486
PA,23833596013359119144
Reuter25473596013359114175211264300
VE,28673596013361116139
Ulbright3026359601337196158193219280340375
TM.34213596013355142167
The36093598013151111164
201637943598013153105153199
WHO40143598013190159233
Classification4267359801316385134173213234260287336385417439497556
of4843359801315987
Tumours49513598013151101190248306338379
of850374801315987
the9623748013142100154
Urinary11483748013169100123181230261314
System14863748013159104145180231321
and18313748013158116176
Male20393748013186136158211
Genital22833748013169123181203236286309
Organs‑Part26243748013174107165214272312343400448479517
A:3165374801317392
Renal,32823748013163117175224247264
Penile,35703748013164115173195217270287
and38813748013158117176
Testicular40823748013159105146181203251309331380412
Tumours.45183748013160110199258316348389409
Eur49513748013159115146
Urol.51303748013169100157180199
2016;8503898013154105153200217
70(1):10913898013154104132180200217
93–105.13323898013154103158204252303320
38.8504046013356112135
Hora10094046013371132168221
M,12534046013389113
Ürge13894046013372107167222
T,1635404601335570
Kalusová17294046013360113139199241302353406
K,2158404601336086
et2267404601335592
al.2382404601335379101
Novelizovaná25084048013170129177229251273317373421471529578
klasifikace3110404801314771119159180206233278329377428
nádorů35634048013159107167225257315
ledvin3902404801312477137186209267
201341934048013154105153198
(International4415404801312951109140191223282330362385442501549572
Society50114048013151109159181233266318
of850419801315987
Urological9614198013169100156179237298319368417440
Pathology14254198013155103135193251275333393441
Vancouver18904198013156103161210266324373425456
Classification2370419801316385134173213234260287335385417439497556
of2950419801315887
Renal30614198013155108166215237
Neoplasia).33224198013170124183243266315354376424450465
Ces38114198013163114154
Urol39894198013169100156179
2014;41924198013154106153200216
18(1):44324198013154101129176196213
9–20.46694198013154111158210228
39.8504346013356110129
Schmidt10064346013354103163254279341377
LS,14074346013355110132
Linehan1563434601335580141196256309369
WM.19594346013393180204
Hereditary21914348013169122154205266287321370402454
leiomyomatosis2669434801312779101159249295352441490523579619640679
and33724348013153111171
renal3567434801313687145194216
cell38074348013153104126148
carcinoma.39794348013153103134181202260318408457476
Int4479434801312785116
J46204348013141
Nephrol46894348013170123183242273329352
Reno‑50694348013156109167225260
vasc,8504498013150100139188207
DiS.1081449801317193142161
2014;12664498013154105153200216
7:1506449801315468
253–260.15984498013153106156211259309363381
40.8504646013357115137
Trpkov1011464601336292155207266318
K,1353464601336894
Hes14784646013372128172
O,1681464601337797
Agaimy18094646013368128181207298348
A,2189464601336893
et23064646013363100
al.2429464601336287110
Fumarate25644648013160115205254286336369420
Hydratase‑deficient30174648013170118177209259292342382436471533587613640689711764822854
Renal38964648013164117176225248
Cell41684648013171123146168
Carcinoma43604648013172122153201223281340430479
Is4864464801313171
Strongly4959464801316091123181240300322370
Correlated8504798013163119151183235257306338389449
With13214798013190114147205
Fumarate15484798013150106194243275325357408
Hydratase19774798013170118176207257289339379432
Mutation24314798013185143176226258280338396
and28494798013150108167
Hereditary30384798013169122153205265287320370401453
Leiomyomatosis35134798013149101123180270316373463512544600640661700
and42354798013150108167
Renal44244798013155108166215237
Cell46834798013163114136158
Carcinoma48634798013162112143190212269328417466
Syndrome.850494801315196155214246302392445462
Am13364948013164154
J15144948013138
Surg15764948013151107139197
Pathol.17974948013155103135193251275293
2016;21144948013154105153200217
40(7):23554948013154108137190219235
865–875.26144948013154108159214269319368385
41.8505096013356105122
Pivovarcikova998509601335983136194246299334382407458516568621
K,1644509601336086
Martinek17555096013389142177216241301356408
P,2189509601335868
Grossmann22835096013371107166209252342395455515
P,2824509601335968
et2918509601335592
al.3036509601335378100
Fumarate31615098013154109197246278328360411
hydratase35985098013159105164195245277327367420
deficient40445098013160113139165214236288346378
renal4446509801313587145193215
cell46865098013151102125146
carcinoma:48575098013151101132179201258317406455472
Chromosomal8505248013163120151208298356396454544593615
numerical14895248013159116205258289312360410432
aberration19455248013150110164195228278310332390448
analysis24175248013150108157179227267289328
of2769524801315887
122880524801315398
cases.3002524801314999139192232251
Ann32775248013165123181
Diagn3482524801317193142201259
Pathol.37655248013155103135193252275293
2019;40825248013154105153198216
39:43225248013154104123
63–68.44695248013154105160217271290
42.8505396013356109132
Kuroda10075396013360118154213276328
N,1361539601337295
Ohe14815396013376138193
C,1699539601336488
Kato18135396013359113149207
I,2044539601332851
et2121539601335591
al.2238539601335378101
Review23665398013156109157180233311
of2704539801315887
hereditary28175398013159112143195255277310360391443
leiomyomatosis3284539801312679100158248294351441490522578618639678
renal3986539801313586144193215
cell42255398013152103125147
carcinoma43965398013151101132179201258317406455
with48785398013179102135193
focus5095539801313188138195234
on8505548013159117
clinical99155480131497193150172220270292
and13075548013150108167
pathobiological14995548013160110142200259319341399422480541562611660683
aspects2206554801315089148203252288330
of2560554801315887
renal2671554801313284142191213
tumors.2908554801313492181239271312331
Pol32635548013156111134
J34215548013138
Pathol.34835548013156104136194252275294
2017;38015548013153105153196209
68(4):40355548013153107135185210227
284–290.42865548013153104160217264316370388
43.8505696013356108129
Plevová998569601335881135186244294346
P,1363569601335867
Hladíková1448569601337196147208232285342392444
A,1911569601336791
Tesařová20205696013354101143196230288339391
M.24295696013388111
Hereditary25605698013168121151202261282315363394445
leiomyomatosis302856980131197192149237282338426474505560599620658
and37065698013149106164
renal3893569801312879136183205
cell4117569801314999121142
cancer4278569801314997154202251282
–45795698013155
HLRCC/multiple46535698013169116169231287327412468490522543602624676
cutaneous8505848013149106140190247300359417457
and13315848013150107167
uterine1522584801315892143174197254308
leimomyomatosis185458480131237698186245334380438527576608664704725764
–26435848013155
MCUL.27225848013185147214262282
Klin3028584801315579101158
Onkol.32105848013174133178235258277
2012;35115848013154105153197215
2537505848013154107
Suppl:38815848013151107167227250267
S55–58.41725848013151103151207258310329
44.8505996013355110129
PrzybycinCG,993599601335788133184243290334355412488551572
Magi‑Galluzzi15785996013387136194215246317366388410466509555577
C,2169599601336283
McKenney22665996013387132187236293350401448
JK.2728599601334095118
Hereditary28615998013168117145193249268298344372420
syndromeswith3295599801314086141196224277362411448540559589643
associated3953599801314985121176221240284313360416
renal4384599801313279133178197
neoplasia:45965998013158107162218238283319337382396
a50065998013149
practi‑5069599801316089135180212231261
cal850614801314997117
guide9866148013160115135192242
to1250614801313286
histologic1355614801315979116148202223278337356402
recognition1779614801313080127181239294314345365420477
in2278614801312076
renal2376614801313079135182202
tumor2599614801313288174231260
resection2881614801313180118169216250270325382
specimens.3282614801314198150198217304355410447465
Adv37666148013165121168
Anat39546148013164120167196
Pathol.41706148013155101131187243264280
2013;44706148013154103148191204
20(4):46946148013154103130177200215
245–263.4929614801315399146199244293342357
45.8506296013357111132
Choyke10146296013364124185236288342
PL,13796296013367117141
Walther15526296013393144169206266322358
MM,19416296013389178202
Glenn2175629601337198153215275
GM,24826296013371160184
et26906296013363100
al.2814629601336186109
Imaging29486298013132121171230253311370
features3343629801313790138170229260312353
of3720629801316796
hereditary38406298013168121153205266288321372403455
papillary43206298013169119179202224246295327379
renal4724629801314092151200222
cancers.49716298013157107166215266298339359
J8506448013138
Comput9126448013163119208268326360
Assist12966448013164106146167206241
Tomogr.15616448013151102192250310342356
1997;1941644801315398152201215
21(5):21806448013153100122172199216
737–741.24206448013154105154202250295340353
46.8506596013356114137
Choueiri10146596013364124184245299325360386
TK,14236596013359119144
Vaishampayan15956596013361111136178239291382444497547600660
U,2283659601337190
Rosenberg24016596013359119162217278340395431492
JE,2916659601334599122
et3065659601335592
al.3180659601335783105
Phase33096598013160116165205258
II3591659801312850
and36656598013154112171
biomarker3864659801316184141231280311357409440
study4329659801314579137197245
of4602659801315987
the4713659801313897150
dual48916598013160117166188
MET/51076598013186136190221
VEGFR28506748013156108175225278332
inhibitor1207674801312078136157217239273329361
foretinib1592674801312684116167200222280302361
in1977674801312178
patients20776748013161111143165218276307349
with24486748013179102135193
papillary26636748013161111170193215237285316368
renal3055674801313182140189211
cell32886748013149100122144
carcinoma.3454674801314999130177199256314404453472
J39506748013136
Clin4008674801316284106163
Oncol.41936748013174133181237260279
2013;44946748013153105153197213
31(2):47296748013154100121172199215
181–186.49666748013154100148197244290344363
47.8506896013356108119
Schmidt9916896013354103164254280341377
LS,13906896013352107129
Nickerson1541689601337298147197250286330390451
ML,20146896013388140164
Angeloni21996896013368128189244270330391416
D,2637689601337392
et2751689601335592
al.2864689601335379101
Early29886898013151101132155203
onset32146898013158117156209242
hereditary34786898013159113144195256277311360392443
papillary39446898013161110170193214236285316368
renal4336689801313182140189211
carcinoma:4569689801314999130177199256315404453470
germ‑50626898013160112144234268
line850704801312345102155
missense10297048013191112151191244302341395
mutations14477048013191148181231263285343401441
in1912704801312380
the2016704801313492145
tyrosine2185704801313486118175215236294347
kinase2556704801314670128176216269
domain28497048013160118208257278336
of3209704801315887
the3320704801313492145
met34897048013190143176
proto‑oncogene.3689704801316193149182238273333392440496557609667720738
J44517048013137
Urol.45127048013169100157180198
2004;47347048013154105160216232
172(44990704801315497149175224
Pt5238704801315591
1):85071980131547491
1256–1261.965719801315398151203261307351402447460
48.8507346013356113136
Menko10057346013388143204254312
FH,13377346013353122144
van15017346013352105164
Steensel1685734601335487141196256298353378
MA,20837346013388154179
Giraud2281734601337196131183243304
S,2604734601335476
et2699734601335591
al.281073460133527799
Birt‑Hogg‑Dubé2930734801315577108145173243301360419452524582641694
syndrome:3644734801314190148207238294383436453
diagnosis4117734801316081129188245303343364402
and45397348013150107166
management.47257348013190138195244303355443496554585604
Lancet8507498013149100158206257290
Oncol.11647498013174133182238261279
2009;14677498013154106161214232
10(12):17237498013154101130177222248265
1199–1206.2012749801315494139193250296341392447466